CDC Website CDC Website

To Join the NPIN community or

Home » Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Tuberculosis Research Advancement Centers (P30 Clinical Trials Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to solicit meritorious applications for the Tuberculosis Research Advancement Centers (TRACs) program. The main goal of these centers is to provide administrative and shared research support to foster and elevate multidisciplinary tuberculosis (TB) research and provide exceptional mentorship to New Investigators. TRACs will provide core facilities, services and mentoring opportunities to achieve the goals of the program.

Letter of Intent Date
5/15/21
Application Due Date
6/15/21
Project Start Date
4/1/22
Application Contact
Jordan
Kindbom
Grants Management Specialist
240-669-2983
kindbomja@mail.nih.gov
Technical Contact
Lakshmi
Ramachandra, MSc, PhD
Program Officer
Lakshmi.ramachandra@mail.nih.gov
301-669-5061
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Subjects
Audiences

Fund Number: 

353342

Fund ID: 

RFA-AI-21-001

Last modified: 

1/13/21